Should Anaerobic Coverage Always Be Included When Streptococcus anginosus Is Isolated?
Yes, anaerobic antimicrobial coverage should be added when Streptococcus anginosus is isolated from soft tissue infections, as this organism is strongly associated with polymicrobial infections involving obligate anaerobes in 70-90% of cases.
Rationale Based on Evidence
The Polymicrobial Nature of S. anginosus Infections
S. anginosus group (SAG) organisms are part of normal oral and genitourinary flora and have a well-established propensity to cause abscess-forming infections alongside anaerobic bacteria. The most recent pediatric data demonstrates that more than 70% of patients infected with S. anginosus were co-infected with obligate anaerobes, with Bacteroides species being significantly associated 1. In adult cohorts, polymicrobial infections occurred in approximately 15% of SAG cases overall, but this rate was notably higher in soft tissue infections specifically 2.
A critical study examining deep tissue infections after soft-tissue sarcoma resection found that 90% of anaerobic-containing infections were polymicrobial, compared to only 52% of purely aerobic infections 3. This underscores that when anaerobes are present, they rarely exist in isolation.
Clinical Context Matters
The IDSA guidelines for skin and soft tissue infections emphasize that empiric antibiotic treatment should be broad when dealing with necrotizing or severe infections, as the etiology can be polymicrobial (mixed aerobic-anaerobic microbes) 4. The guidelines specifically note that infections involving the axilla or perineum require metronidazole plus either a fluoroquinolone or ceftriaxone to cover anaerobes 4.
Site-Specific Considerations
The location of infection influences the likelihood of anaerobic co-infection:
- Genitourinary tract infections: S. anginosus is the predominant SAG species isolated from balanoposthitis in children, and these infections frequently involve anaerobes 1
- Intra-abdominal and hepatobiliary infections: SAG commonly causes hepatic abscesses, which are typically polymicrobial 2
- Deep soft tissue infections: A recent case report documented S. anginosus empyema progressing to necrotizing fasciitis with retroperitoneal abscesses, requiring aggressive surgical debridement 5
Timing of Presentation
An important clinical clue: infections presenting later than 53 days post-procedure had an 81% accuracy for predicting anaerobic involvement in one surgical cohort 3. The median time to debridement for anaerobic infections was 54.5 days versus 29.5 days for purely aerobic infections (p=0.004).
Practical Antibiotic Selection
When S. anginosus is isolated from tissue samples, appropriate regimens with anaerobic coverage include:
Single-Agent Options:
- Piperacillin-tazobactam 3.375-4.5g IV every 6-8 hours 4
- Carbapenems (imipenem, meropenem, or ertapenem) 4
- Ampicillin-sulbactam 3g IV every 6 hours 4
Combination Regimens:
- Ceftriaxone 1g IV daily PLUS metronidazole 500mg IV every 8 hours 4
- Fluoroquinolone (levofloxacin 750mg daily or ciprofloxacin 400mg every 12h) PLUS metronidazole 4
Antimicrobial Susceptibility
While SAG organisms maintain excellent susceptibility to beta-lactams (100% to penicillin, ampicillin, and ceftriaxone in most series 1; 84-94% to penicillin/ampicillin in others 2), the polymicrobial nature of these infections necessitates broader coverage. Resistance to clindamycin (46% resistant) and erythromycin (35% resistant) is concerning 2, making these agents less reliable for empiric monotherapy.
Critical Pitfalls to Avoid
Do not assume monomicrobial infection: Even when only S. anginosus grows in culture, anaerobes may be present but not cultured due to sampling or laboratory limitations
Do not use narrow-spectrum agents initially: Despite SAG susceptibility to penicillin, the high rate of polymicrobial infection requires broader initial coverage
Do not delay surgical intervention: 74-92% of SAG soft tissue infections require surgical drainage 6, 2. Antibiotics alone are insufficient for abscess-forming infections
Consider MRSA coverage in severe infections: The IDSA guidelines recommend adding vancomycin or linezolid to anaerobic coverage for necrotizing infections 4
When Anaerobic Coverage May Be Narrowed
Once culture results confirm S. anginosus as a true monomicrobial infection (not just the only organism that grew), and the patient demonstrates clinical improvement with source control, you may consider de-escalating to targeted therapy. However, this decision should be made cautiously, particularly for deep-seated or incompletely drained infections.
The evidence strongly supports that initial empiric therapy for S. anginosus soft tissue infections should include anaerobic coverage given the 70-90% rate of polymicrobial infection, with subsequent de-escalation guided by clinical response and definitive culture results.